.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Medtronic
Mallinckrodt
Fish and Richardson
Colorcon
US Department of Justice
Daiichi Sankyo
UBS
Novartis
QuintilesIMS

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077263

« Back to Dashboard

NDA 077263 describes RIZATRIPTAN BENZOATE, which is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Mylan Pharms Inc, Natco Pharma Ltd, Panacea Biotec Ltd, Sandoz, Unichem Labs Ltd, Alkem Labs Ltd, Cipla Ltd, Eci Pharms Llc, Emcure Pharms Ltd, Glenmark Generics, Invagen Pharms, and Teva Pharms, and is included in twenty-five NDAs. It is available from twenty-six suppliers. Additional details are available on the RIZATRIPTAN BENZOATE profile page.

The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

Summary for 077263

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antimigraine Agents

Pharmacology for NDA: 077263

Suppliers and Packaging for NDA: 077263

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 077263 ANDA Teva Pharmaceuticals USA Inc 0093-7471 0093-7471-43 18 BLISTER PACK in 1 BOX (0093-7471-43) > 1 TABLET in 1 BLISTER PACK (0093-7471-19)
RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 077263 ANDA Teva Pharmaceuticals USA Inc 0093-7472 0093-7472-43 18 BLISTER PACK in 1 BOX (0093-7472-43) > 1 TABLET in 1 BLISTER PACK (0093-7472-19)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 5MG BASE
Approval Date:Dec 31, 2012TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Dec 31, 2012TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Mallinckrodt
Fish and Richardson
Cantor Fitzgerald
Argus Health
Moodys
UBS
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot